Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

European Ombudsman demands EFSA admits failure over revolving door

  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska

Munich/ Brussels, 8 December 2011: The European Ombudsman has ruled in favour of a complaint filed by Testbiotech against the European Food Safety Authority (EFSA) regarding its approach to the 'revolving door'. The case concerns a former senior staff member at EFSA, Dr Suzy Renckens, who was head of the unit responsible for the risk assessment of genetically engineered plants for five years until 2008. Dr Renckens, a Belgian national, then moved to a job at Syngenta, a company that produces and markets these plants. The European Ombudsman has now agreed with Testbiotech's complaint and ruled that “EFSA should acknowledge that it failed to observe the relevant procedural rules and to carry out a sufficiently thorough assessment of the potential conflict of interests arising from the move of a former member of its staff to a biotechnology company”[1]. 

“The ruling from the Ombudsman shows in detail that EFSA failed to fulfill its obligations,” said Christoph Then from Testbiotech. “We are very concerned that both EFSA and the Commission have tried to deny their responsibilities in this case by rejecting our original complaints. The authority and the European Commission, which backs EFSA, are eroding confidence in European institutions. In consequence they are putting at risk the protection of consumers and the environment.”

Olivier Hoedeman from Corporate Europe Observatory said: “There have been other cases of staff going through the revolving door; EFSA should look carefully at the ruling and introduce a far stricter approach to conflicts of interest in the future. The Ombudsman makes some important recommendations which should lead to changes in how revolving door rules are implemented across the EU institutions, including at the Commission. We continue to see further scandalous revolving doors cases [2] and it is vital that the EU institutions, starting with the Commission, put improved rules and procedures in place to prevent future conflicts of interest, including a cooling off period of several years. It is time for a new start. No more business as usual.”

The Suzy Renckens case was made public by Testbiotech in November 2009 and the complaint was supported by Corporate Europe Observatory (CEO), Friends of the Earth Europe (FoEE) and Lobbycontrol (in Germany)[3]. EFSA now has until 31 March 2012 to respond to the judgement of the EU Ombudsman who has the power to table the issue in the European Parliament.

ENDS

Contact:

Testbiotech: Christoph Then, Tel +49 15154638040, info@testbiotech.org

CEO: Vicky Cann, Corporate Europe Observatory, tel: +32 28 93 09 30, mobile: +32 489 596 478

Notes:

[1] A link to the full ruling from the European Ombudsman can be found here: http://www.testbiotech.de/en/node/588

[2] CEO's RevolvingDoorWatch was launched on 7 December and it presents details of many other revolving door cases, including other cases at EFSA, and others concerning food industry lobbyists: http://www.corporateeurope.org/projects/revolvingdoorwatch

[3] All documents related to this complaint can be found here: http://www.testbiotech.de/independence

Related issues: 
 

NGOs criticise move by ex-commissioner and now MEP Viviane Reding to join the board of Nyrstar mining company.
Now that the dust has settled on the hearings of the commissioners-designate in the European Parliament, it is time for some critical reflections on the messy, partisan and in several other ways fundamentally flawed process for appointing arguably the most powerful people in the whole EU infrastructure.
Is it appropriate to let a former board member of a Deutsche Bank investment fund go straight from there to a key position in the new European supervisory structure for banks? What's the problem with hiring people with strong links to financial corporations to monitor the big banks? Or to be part of decisions on whether measures to ensure financial stability should be imposed on them or not? And can they keep working in the financial sector at the same time? If you ask the European Central Bank, there is absolutely no problem with this scenario.
Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.
An analysis of the revised independence policy of the European Food Safety Authority (EFSA). More reworded than revised, actually.
The EU's Comprehensive Economic and Trade Agreement (CETA) with Canada could unleash a wave of corporate lawsuits against Canada, the EU and its member states – including through the Canadian subsidiaries of US multinational corporations. This is the result of an in-depth analysis of CETA’s investor rights by Corporate Europe Observatory and 14 other environmental NGOs, citizens’ groups and workers unions from both sides of the Atlantic published today.
The position of Chief Scientific Adviser to the President of the European Commission has been discontinued, and the Juncker Commission says it is now reflecting on how to organise independent scientific advice. This is a crucial issue and, together with many other NGOs, we sent a list of principles to the Commission on how to, in our opinion, try to best do this.
This 10-minute video exposes the role corporate lobbies have in EU decision-making, how they manage to get what they want and how their activities affect citizens all over Europe.

Corporate Europe Forum